Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

November 8, 2016 11:25 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment